Suppr超能文献

乳腺钼靶筛查频率对乳腺癌死亡率的影响。

Impact of Mammography Screening Frequency on Breast Cancer Mortality Rates.

作者信息

Abu Abeelh Enas, AbuAbeileh Zain

机构信息

Diagnostic Radiology, West Bay Medicare, Doha, QAT.

Radiology, King Hussein Medical Center, Amman, JOR.

出版信息

Cureus. 2023 Nov 19;15(11):e49066. doi: 10.7759/cureus.49066. eCollection 2023 Nov.

Abstract

The frequency of mammography screening remains a topic of ongoing debate. This meta-analysis aimed to investigate the impact of annual vs. biennial mammography screenings on breast cancer mortality rates. A comprehensive search of relevant literature published up to 2021 was performed, with the primary outcome being the difference in breast cancer mortality rates between annual and biennial screenings. The extracted data included relative risks and 95% confidence intervals (CIs), with studies selected based on predetermined inclusion and exclusion criteria, emphasizing the quality of methodology and minimization of bias. Of the included studies, thirteen met the criteria, covering diverse demographic cohorts and screening frequencies. The synthesized data revealed a pattern of lower relative risk in annual screenings compared to biennial screenings across all studies. Notably, subgroup analyses indicated that age and racial background might modulate the effectiveness of screening frequency. In conclusion, this meta-analysis offers strong evidence suggesting that annual mammography screenings could be more effective than biennial screenings in reducing breast cancer mortality rates, especially in certain high-risk demographics. The results emphasize the importance of personalized, evidence-based approaches to mammography, with a call for future research to validate these findings and delve deeper into optimizing breast cancer screening strategies.

摘要

乳腺钼靶筛查的频率仍是一个持续争论的话题。这项荟萃分析旨在调查每年一次与每两年一次的乳腺钼靶筛查对乳腺癌死亡率的影响。对截至2021年发表的相关文献进行了全面检索,主要结果是每年一次和每两年一次筛查之间乳腺癌死亡率的差异。提取的数据包括相对风险和95%置信区间(CIs),研究根据预先确定的纳入和排除标准进行选择,强调方法学质量和偏差最小化。在所纳入的研究中,有13项符合标准,涵盖了不同的人口队列和筛查频率。综合数据显示,在所有研究中,每年一次筛查的相对风险低于每两年一次筛查。值得注意的是,亚组分析表明年龄和种族背景可能会调节筛查频率的有效性。总之,这项荟萃分析提供了有力证据,表明每年一次的乳腺钼靶筛查在降低乳腺癌死亡率方面可能比每两年一次的筛查更有效,特别是在某些高危人群中。结果强调了个性化、循证乳腺钼靶检查方法的重要性,呼吁未来的研究验证这些发现并更深入地探讨优化乳腺癌筛查策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81fd/10730471/ac1686771610/cureus-0015-00000049066-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验